GO
Loading...

Cramer: AbbVie-Shire driven by inversion

Friday, 20 Jun 2014 | 9:07 AM ET

British drug maker Shire has rejected a $46 billion takeover offer from U.S. based AbbVie. CNBC's Jim Cramer discusses the latest attempt by a U.S. health care company to tap into the low foreign tax rate.